Low abundant TH17 pathway biomarker monitoring

 

Leveraging TH17 and other pathway biomarkers in inflammatory diseases is highly challenging due to their low abundance.

The high-definition Erenna® Immunoassay System, powered by patented Single Molecule Counting (SMC™) technology by Singulex, enables you to quantify the previously undetectable.

  • Generate relevant data for critical decision making and reduction of program costs
  • Accurately measure low abundance biomarkers in all subjects, including healthy and disease states
  • Accelerate discovery and uncover novel biology 
  • Measure from small volumes to conserve precious samples

 

See how Singulex technology has been used as the solution of choice to accelerate discovery and uncover novel biology.

 


For research use only and not intended for diagnostic use.

See more data now.

Copyright© 2014 Singulex, Inc. All rights reserved.
Singulex®, Erenna®, and SMC™ are trademarks or registered trademarks of Singulex, Inc.